Cargando…
MB4-2/MB4-3 transcripts of IGH-MMSET fusion gene in t(4;14)(pos) multiple myeloma indicate poor prognosis
Multiple myeloma (MM) patients with t(4;14) is a heterogeneous group. Prognostic tools capable of predicting the outcome of patients are currently lacking. The MM SET domain (MMSET) protein is universally overexpressed and has been suggested to have an important tumorigenic role. This study analyzed...
Autores principales: | Li, Feng, Zhai, Yong-Ping, Lai, Ting, Zhao, Qian, Zhang, Hui, Tang, Yu-Mei, Hou, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584273/ https://www.ncbi.nlm.nih.gov/pubmed/28881672 http://dx.doi.org/10.18632/oncotarget.18209 |
Ejemplares similares
-
MMSET is the key molecular target in t(4;14) myeloma
por: Mirabella, F, et al.
Publicado: (2013) -
Plasma Membrane Proteomics Identifies Biomarkers Associated with MMSET Overexpression in T(4;14) Multiple Myeloma
por: Xie, Zhigang, et al.
Publicado: (2013) -
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
por: Longo, Joseph, et al.
Publicado: (2020) -
The snoRNA target of t(4;14) in multiple myeloma regulates ribosome biogenesis
por: Oliveira, Vanessa, et al.
Publicado: (2019) -
Lifting tools & MB4 rail
por: Lucien Veillet
Publicado: (2002)